All In Biotech

Drug Trial Radar · NCT06117774

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Last checked: Nov 20, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 404 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

404

Actual

Start

Feb 20, 2024

Primary completion

Apr 20, 2030

Study completion Apr 20, 2030

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Nov 7, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to compare the efficacy of tarlatamab with placebo as assessed by progression free survival (PFS) based on blinded independent central review (BCIR) per response evaluation criteria in solid tumors v1.1 (RECIST 1.1) and on prolonging overall survival (OS).

Conditions

  • Limited Stage Small Cell Lung Cancer
  • Small Cell Lung Cancer

Interventions

  • TarlatamabDrug

    Intravenous (IV) infusion

  • PlaceboDrug

    IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PFS as Determined by BICRTime frame: Up to approximately 6 years
  2. OS Over the Whole TrialTime frame: Up to approximately 6 years

Locations

204 sites in 27 countries. Site status is shown where the registry gives one.

  • Valkyrie Clinical Trials

    Los Angeles, California

  • University of California Los Angeles

    Santa Monica, California

  • Yale New Haven Hospital

    New Haven, Connecticut

  • Boca Raton Clinical Research Global South Florida

    Plantation, Florida

  • University of Louisville James Graham Brown Cancer Center

    Louisville, Kentucky

  • Our Lady of the Lake Cancer Institute

    Baton Rouge, Louisiana

  • Morristown Medical Center

    Morristown, New Jersey

  • New York University Grossman School of Medicine and New York University Langone Hospitals

    New York, New York

  • Perlmutter Cancer Center at New York University Langone Hospital - Long Island

    New York, New York

  • Montefiore Einstein Center for Cancer Care

    The Bronx, New York

  • FirstHealth Cancer Center

    Pinehurst, North Carolina

  • Lehigh Valley Health Network

    Allentown, Pennsylvania

  • Spokenword Clinical Trials

    Easton, Pennsylvania

  • Renovatio Clinical

    The Woodlands, Texas

  • US Oncology Research Investigational Products Center

    The Woodlands, Texas

  • University of Virginia Health System

    Charlottesville, Virginia

  • Virginia Cancer Specialists, PC

    Fairfax, Virginia

  • West Virginia University Health Sciences Center

    Morgantown, West Virginia

  • Instituto Argentino de Diagnóstico y Tratamiento

    Buenos Aires, Argentina

  • Fundacion Respirar

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Hospital Italiano de La Plata

    La Plata, Buenos Aires, Argentina

  • Hospital Universitario Austral

    Pilar, Buenos Aires, Argentina

  • Instituto Oncologico de Cordoba Ionc Fundacion Richardet Longo

    Córdoba, Córdoba Province, Argentina

  • Hospital Aleman Buenos Aires

    CABA, Distrito Federal, Argentina

  • Clinica Viedma

    Viedma, Río Negro Province, Argentina

  • Sanatorio 9 de Julio Cice 9 de Julio

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Port Macquarie Base Hospital

    Port Macquarie, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Flinders Medical Centre

    Bedford Park, South Australia, Australia

  • Monash Medical Centre

    Clayton, Victoria, Australia

  • Fiona Stanley Hospital

    Murdoch, Western Australia, Australia

  • Medizinische Universitaet Graz

    Graz, Austria

  • Universitaetsklinikum Allgemeines Krankenhaus Wien

    Vienna, Austria

  • Institut Jules Bordet

    Brussels, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Instituto Dor de Pesquisa e Ensino

    Rio de Janeiro, Brazil

  • Instituto Cancer Sao Paulo Icesp

    São Paulo, Brazil

  • Hospital Santa Rita

    Vitória, Espírito Santo, Brazil

  • Oncoclinicas Onco Vida Distrito Federal

    Brasília, Federal District, Brazil

  • Liga Paranaense do Combate ao Cancer - Hospital Erasto Gaertner

    Curitba, Paraná, Brazil

Showing 40 of 204 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.